Co-Authors
This is a "connection" page, showing publications co-authored by Peter Verhamme and B De Tavernier.
Connection Strength
0.115
-
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020 Dec 29; 21(1):1033.
Score: 0.058
-
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020 Dec 09; 21(1):1005.
Score: 0.057